Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
This trial is active, not recruiting.
|Condition||stress disorders, post-traumatic|
|Sponsor||VA Office of Research and Development|
|Start date||August 2010|
|End date||August 2015|
|Trial size||102 participants|
|Trial identifier||NCT01120067, D6281-I|
This study is investigating the efficacy of an intensive (3 week) integrated treatment for Veterans with both pain and PTSD.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
The Clinician Administered Assessment of PTSD (CAPS)
time frame: 6 months
Male or female participants at least 18 years old.
- Patients will be eligible to participate if they have constant pain of at least three months duration with a neurologic or musculoskeletal etiology.
- Patients must also meet diagnostic criteria for PTSD.
- Patients with life threatening or acute physical illness, current alcohol or substance abuse, current psychosis or suicidal ideation, and individuals seeking pain treatment such as surgical interventions will be excluded.
|Official title||Intensive Treatment of Chronic Pain and PTSD for OEF/OIF Veterans|
|Principal investigator||John Otis, BS BA PhD|
|Description||Objectives: The primary objective of this study is to evaluate the efficacy of an intensive integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder (PTSD). A secondary objective is to examine potential mechanisms of action that might account for improvements in pain or PTSD. Third, exploratory analyses will be conducted to assess the relationship between participation in treatment and cognitive functioning. It is hypothesized that 1) participants receiving the intensive treatment (PT) will report significantly greater decreases in symptoms of pain and PTSD from pre-treatment to post-treatment when compared to participants randomized to a standard care (SC) condition, and 2) participants receiving PT will show greater maintenance of change on measures of pain and PTSD at 3 months following the completion of treatment when compared to participants randomized to the SC condition.|
Call for more information